<SUBMISSION>
<ACCESSION-NUMBER>0000950134-08-021788
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>4
<PERIOD>20081208
<ITEMS>5.02
<ITEMS>9.01
<FILING-DATE>20081208
<DATE-OF-FILING-DATE-CHANGE>20081208
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>IMMERSION CORP
<CIK>0001058811
<ASSIGNED-SIC>3577
<IRS-NUMBER>943180138
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-27969
<FILM-NUMBER>081236010
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>801 FOX LANE
<CITY>SAN JOSE
<STATE>CA
<ZIP>95131
<PHONE>4084671900
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>801 FOX LANE
<CITY>SAN JOSE
<STATE>CA
<ZIP>95131
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>IMMERSION HUMAN INTERFACE CORP
<DATE-CHANGED>19980602
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f50765e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): December&nbsp;8, 2008</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>IMMERSION CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center" style="font-size: 10pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">000-27969
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">94-3180138</TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">801 Fox Lane<BR>
San Jose, California 95131<BR>
(Address of principal executive offices) (Zip Code)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 0pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code: (408)&nbsp;467-1900</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Not Applicable<BR>
(Former name or former address, if changed since last report)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>







<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">Item&nbsp;9.01 Financial Statements and Exhibits</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="f50765exv99w1.htm">EX-99.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="f50765exv99w2.htm">EX-99.2</A></TD></TR>
<TR><TD colspan="9"><A HREF="f50765exv99w3.htm">EX-99.3</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>






<!-- link1 "Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;On December&nbsp;8, 2008, Immersion Corporation (the &#147;Company&#148;) announced that it has appointed
Daniel J. Chavez as Senior Vice President and General Manager of the Company&#146;s Medical Line of
Business, effective December&nbsp;1, 2008. Mr.&nbsp;Chavez, age 51, previously served as interim Senior Vice
President and General Manager of the Company&#146;s Medical Line of Business since August&nbsp;2008. From
January&nbsp;2007 to July&nbsp;2008, Mr.&nbsp;Chavez was a health information technology consultant focused on
business planning, strategic alliance development, product management and marketing. From
September&nbsp;2001 to December&nbsp;2006, Mr.&nbsp;Chavez held various positions at Availity, LLC, a healthcare
transactions and professional services company, including Senior Vice President, Operations, Vice
President, Operations and Vice President, Business Development. Prior to September&nbsp;2001, Mr.
Chavez held positions with Emstat Corporation, Computer Sciences Corporation, Stellcom
Technologies, Inc., Science Applications International Corporation, GTE Corporation and IBM
Corporation. Mr.&nbsp;Chavez holds a M.B.A. from Stanford University, and B.A. in Economics from San
Jose State University.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In connection with the appointment of Mr.&nbsp;Chavez, the Company has entered into an offer of
employment with Mr.&nbsp;Chavez (the &#147;Offer Letter&#148;) dated November&nbsp;25, 2008. Pursuant to the Offer
Letter, Mr.&nbsp;Chavez will be employed as Senior Vice President and General Manager of the Company&#146;s
Medical Line of Business at salary of $245,000 per annum, and will receive a sign on bonus in the
amount of $25,000 to be paid within his first week of employment; this bonus must be reimbursed on
a pro rata basis to the Company in the event Mr.&nbsp;Chavez voluntarily terminates his employment prior
to December&nbsp;1, 2009. Upon approval by the Company&#146;s Board of Directors, Mr.&nbsp;Chavez will be
eligible to participate in the Company&#146;s 2009 executive bonus plan with a target annual bonus
amount of $147,000. Mr.&nbsp;Chavez is also eligible for one year of relocation assistance, including
tax grossed-up payment of moving costs, fees related to closing costs, up to 60&nbsp;days of temporary
housing, travel expenses for two house hunting trips and a $15,000 discretionary move bonus for
incidental costs. In the event that Mr.&nbsp;Chavez terminates his employment with the Company within
the first year of his actual move date, Mr.&nbsp;Chavez will be required to repay all or part of these
relocation payments. Mr.&nbsp;Chavez will be granted an option to purchase 175,000 shares of common
stock of the Company pursuant to the Company&#146;s 2008 Employment Inducement Award Plan (the
&#147;Option&#148;). The Option will vest over four years at the rate of 25% on the one year anniversary of
the commencement of employment, and thereafter in equal monthly installments at the rate of 1/48th
per month over the remaining 36&nbsp;months. A copy of the Offer Letter is attached hereto as Exhibit
99.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has also entered into an indemnification agreement with Mr.&nbsp;Chavez in form and
substance substantially as previously filed by the Company as an exhibit to its annual report on
Form 10-K filed with the Securities and Exchange Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has also entered into a retention and ownership change event agreement (the
&#147;Retention Agreement&#148;) with Mr.&nbsp;Chavez in form attached hereto as Exhibit&nbsp;99.2. The Retention
Agreement provides for the payment of severance and health insurance premiums upon the occurrence
of certain events. In the event that his employment with the Company is
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">terminated by the Company without cause, Mr.&nbsp;Chavez will be entitled to receive a lump sum
severance payment equal to 6&nbsp;months base salary and payments of health insurance premiums for
the earlier of 6&nbsp;months or the date on which Mr.&nbsp;Chavez first becomes eligible to obtain other
group health insurance coverage. In the event that Mr.&nbsp;Chavez&#146;s employment with the Company is
terminated by the Company without cause, or is terminated by him with good reason, in either case,
in connection with an ownership change event of the Company, then Mr.&nbsp;Chavez will also be entitled
to receive a lump sum severance payment equal to 12&nbsp;months base salary and payments of health
insurance premiums for the earlier of 12&nbsp;months or the date on which Mr.&nbsp;Chavez first becomes
eligible to obtain other group health insurance coverage. Payment of the foregoing benefits will
be conditioned upon Mr.&nbsp;Chavez&#146;s execution of a general release of claims.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the press release dated December&nbsp;8, 2008 announcing Mr.&nbsp;Chavez&#146;s appointment is
attached hereto as Exhibit&nbsp;99.3.
</DIV>
<!-- link1 "Item&nbsp;9.01 Financial Statements and Exhibits" -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Exhibits.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Offer Letter dated November&nbsp;25, 2008 by and between Immersion
Corporation and Daniel J. Chavez</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Retention and Ownership Change Event Agreement dated December
4, 2008 by and between Immersion Corporation and Daniel J.
Chavez</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Press Release dated December&nbsp;8, 2008 regarding the appointment
of Daniel J. Chavez as Senior Vice President and General
Manager of Immersion&#146;s Medical Line of Business</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Date: December&nbsp;8, 2008</TD>
    <TD colspan="3" align="left"><B>IMMERSION CORPORATION</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left"><I>/s/ Stephen M. Ambler</I>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Stephen M. Ambler&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Financial Officer and Vice President, Finance&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT INDEX</U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Offer Letter dated November&nbsp;25, 2008 by and between Immersion
Corporation and Daniel J. Chavez</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Retention and Ownership Change Event Agreement dated December
4, 2008 by and between Immersion Corporation and Daniel J.
Chavez</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Press Release dated December&nbsp;8, 2008 regarding the appointment
of Daniel J. Chavez as Senior Vice President and General
Manager of Immersion&#146;s Medical Line of Business</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f50765exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;IMMERSION LETTERHEAD&#093;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">November&nbsp;25, 2008
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dan Chavez<BR>
157 North River Drive<BR>
St Augustine, FL 32095

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">RE: &nbsp; Employment with Immersion Corporation
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dear Dan:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This offer supersedes the previous offer dated November&nbsp;17, 2008.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immersion Corporation (the &#147;Company&#148; or &#147;Immersion&#148;) is pleased to present this offer for the
position of Senior Vice President &#038; General Manager, Immersion, Medical Line of Business, on the
terms set forth in this agreement, effective upon your acceptance by execution of a counterpart
copy of this letter where indicated below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reporting Duties and Responsibilities</U><B>. </B>In this position, you will report to the
Company&#146;s President and CEO, Clent Richardson.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%"><U>Salary and Benefits</U>. Your initial base salary will be $245,000.00 annually, payable
in accordance with the Company&#146;s customary payroll practice, which is bi-weekly. This offer
is for a full-time, salaried, exempt position. In addition, you will receive a sign on
bonus in the amount of $25,000.00 to be paid within your first week of employment. Should
you leave voluntarily within your first year of employment with Immersion, the sign on bonus
will be required to be repaid on a prorated basis. Your performance will be reviewed in
January&nbsp;2010 during our Company&#146;s focal review process, and annually thereafter, at which
time you may receive an annual merit increase.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Further, upon approval by the Company&#146;s Board of Directors (the &#147;Board&#148;), you will be
eligible for a bonus in accordance with the Company&#146;s 2009 Executive Incentive Plan of up to
60% of your salary. Details of the bonus plan will be communicated to you during the
implementation in January&nbsp;2009.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Additionally, the company will offer you the following relocation assistance:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Movement of household goods &#150; <I>tax grossed-up</I></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Reimbursement of closing costs on the sale of your home (commission &#038; related
closing costs) and on the purchase of your new home in the Gaithersburg area. &#150; <I>tax
grossed-up</I></TD>
</TR>


</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Temporary housing up to 60&nbsp;days &#150; <I>tax grossed-up</I></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Two (2)&nbsp;house hunting trips for you and your spouse, up to two (2)&nbsp;nights a piece</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A $15,000 discretionary move bonus to cover incidentals &#150; <I>tax grossed-up</I></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><FONT style="font-family: Wingdings">&#167;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This relocation program will expire on December&nbsp;1, 2009; all or part is recoverable
within the first year of the actual move date, if you leave Immersion.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Options</U>. Subject to the approval of the Board, the Company will grant you an
option to purchase 175,000 shares of the Company&#146;s Common Stock pursuant to the Company&#146;s 2008
Employment Inducement Award Plan and standard stock option agreement in effect at that time. All
shares of stock subject to your option will have an exercise price equal to the fair market value
of the Company&#146;s Common Stock at the date of grant. So long as you remain employed by the Company,
your option will become exercisable over a four-year period with 25% of the shares vesting at the
end of your first twelve months of service, and an additional 2.083% vesting at the end of each
month thereafter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change of Control Benefits</U>. Subject to the approval of the Compensation Committee of
the Board, the Company will enter into the Retention and Ownership Change Event Agreement,
enclosed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidential Information</U>. As an employee of the Company, you will have access to
certain Company confidential information and you may during the course of your employment, develop
certain information or inventions that will be the property of the Company. To protect the
interest of the Company, you will need to sign the Company&#146;s standard &#147;Employee Inventions and
Confidentiality Agreement&#148; as a condition of your employment. A copy of the agreement is attached
for your review. We wish to impress upon you that we do not wish you to bring with you any
confidential or proprietary material of any former employer or to violate any other obligation to
your former employers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>At-Will Employment</U>. While we look forward to a long and profitable relationship,
should you decide to accept our offer, you will be an at-will employee of the Company, which means
the employment relationship can be terminated by either of us for any reason at any time. Any
statements or representations to the contrary (and indeed, any statements contradicting any
provision in this letter) are ineffective. Further, your participation in any stock option or
benefit program is not an assurance of continued employment for any particular period of time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization to Work</U>. The Immigration Reform and Control Act of 1986 requires you,
within three business days of hire, to present documentation demonstrating that you have
authorization to work in the United States. Acceptable documentation is shown on the enclosed form
titled <I>Employment Eligibility Verification </I>(Form <I>I-9</I>). Please bring this form, along with the
appropriate documentation, to the new employee orientation on your first day of employment. If you
have questions about this requirement, which applies to U.S. citizens and non-U.S. citizens alike,
please contact our Human Resources department.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Offer</U>. This offer will remain open until close of business on November&nbsp;25,
2008. If you decide to accept our offer, and we hope that you will, please sign the enclosed copy
of this letter in the space indicated and return it to me. Upon your signature below, this
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">agreement and the other agreements referenced herein will become our binding agreement with respect
to the subject matter of this letter (although the Retention and Ownership Change Event Agreement
and eligibility for the Company&#146;s Executive Incentive Plan will only become effective as described
above), superseding in their entirety all other or prior agreements by you with the Company as to
the specific subjects addressed in this letter. This agreement will be binding upon and inure to
the benefit of our respective successors and assigns, and heirs, administrators and executors, will
be governed by California law, and may only be amended in a writing signed by you and an authorized
officer of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Start Date</U>. This offer is made with the understanding that you will start employment
with Immersion on December&nbsp;1, 2008. For purposes of this Agreement, the term &#147;start date&#148; shall
mean the day on which you commence employment with the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are excited and pleased to have you join the Immersion team in this exciting role and we
look forward to a mutually beneficial working relationship.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Sincerely,
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="14%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Clent Richardson
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Clent Richardson <BR>
President &#038; CEO
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Janice Passarello
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Janice Passarello <BR>
Vice President, Human Resources
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><u> AGREED AND ACCEPTED</u></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>X /s/ </B>Daniel J. Chavez
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Daniel J. Chavez
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>November&nbsp;26, 2008</B>
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Date
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>f50765exv99w2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.2
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>RETENTION AND OWNERSHIP<BR>
CHANGE EVENT AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amended and Restated Retention and Ownership Change Event Agreement (&#147;Agreement&#148;) is made
effective as of the last date set forth below by and between Immersion Corporation (the &#147;Company&#148;)
and <B>Daniel J. Chavez </B>(&#147;Executive&#148;).
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>RECITALS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to make available compensation pursuant to this Agreement that will not be subject to
taxation under Section&nbsp;409A (as defined below), Executive and the Board of Directors of the Company
(the &#147;Board&#148;) have determined that it is in the best interests of the Company and Executive to
offer the Retention and Ownership Change Event Agreement by and between the Company and Executive.
The Company intends that income provided to Executive pursuant to this Agreement will not be
subject to taxation under Section&nbsp;409A, and the provisions of this Agreement shall be interpreted
and construed in favor of satisfying any applicable requirements of Section&nbsp;409A. <B>However, the
Company does not guarantee any particular tax effect for income provided to Executive pursuant to
this Agreement. </B>In any event, except for the Company&#146;s responsibility to withhold applicable
income and employment taxes from compensation paid or provided to Executive, the Company shall not
be responsible for the payment of any applicable taxes on compensation paid or provided to
Executive pursuant to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board has determined that it is in the best interests of the Company to assure that the
Company will have the continued dedication and service of the Executive, notwithstanding the
possibility or occurrence of a Change in Control (as defined below) of the Company.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AGREEMENT</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In recognition thereof, the parties now agree as follows:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Definitions</U>. For purposes of this Agreement:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>&#147;Change in Control&#148; means the occurrence of any of the following:</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange
Act of 1934, as amended (the &#147;Exchange Act&#148;)) becomes the &#147;beneficial owner&#148; (as defined in Rule
13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company
representing more than fifty percent (50%) of the total combined voting power of the Company&#146;s
then-outstanding securities entitled to vote generally in the election of the Company&#146;s Board of
Directors; provided, however, that the following acquisitions shall not constitute a Change in
Control: (1)&nbsp;an acquisition by any such person who on the effective date of such transaction is the
beneficial owner of more than fifty percent (50%) of such voting power, (2)&nbsp;any acquisition
directly from the Company, including, without limitation, a public offering of securities, (3)&nbsp;any
acquisition by the Company, (4)&nbsp;any acquisition by a trustee or other fiduciary under an employee
benefit plan of the Company or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(5)&nbsp;any acquisition by an entity owned directly or indirectly by the stockholders of the Company in substantially the
same proportions as their ownership of the voting securities of the Company; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;an Ownership Change Event or series of related Ownership Change Events (collectively, a
&#147;Transaction&#148;) in which the stockholders of the Company immediately before the Transaction do not
retain immediately after the Transaction direct or indirect beneficial ownership of more than fifty
percent (50%) of the total combined voting power of the outstanding securities entitled to vote
generally in the election of Directors or, in the case of an Ownership Change Event described in
Section&nbsp;1(c)(iii), the entity to which the assets of the Company were transferred (the
&#147;Transferee&#148;), as the case may be; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;a liquidation or dissolution of the Company;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provided, however, that a Change in Control shall be deemed not to include a transaction described
in subsections (i)&nbsp;or (ii)&nbsp;of this Section 1(a) in which a majority of the members of the Board of
Directors of the continuing, surviving or successor entity, or parent thereof, immediately after
such transaction is comprised of incumbent members. Notwithstanding the foregoing, to the extent
that any amount that constitutes deferred compensation subject to and not exempted from the
requirements of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (&#147;Section&nbsp;409A&#148;),
would become payable under this Agreement by reason of a Change in Control, such amount shall
become payable only if the event constituting a Change in Control would also constitute a change in
ownership or effective control of the Company or a change in the ownership of a substantial portion
of the assets of the Company within the meaning of Section&nbsp;409A.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &#147;Good Reason&#148; means any of the following conditions, which condition(s) remain(s) in
effect thirty (30)&nbsp;days after written notice to the Board or the Company&#146;s Chief Executive Officer
from Executive of such condition(s):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;a material decrease in Executive&#146;s base salary, other than a material decrease that
applies generally to other executives of the Company at Executive&#146;s level;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;a material, adverse change in the Executive&#146;s title, authority, responsibilities, or
duties; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;the relocation of the Executive&#146;s work place for the Company to a location that is more
than forty (40)&nbsp;miles distant from Executive&#146;s present work location for the Company;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provided, that such written notice must be given within thirty (30)&nbsp;days following the first
occurrence of any of the good reason conditions set forth in this subsection (b)&nbsp;and the
Executive&#146;s resignation must occur within six (6)&nbsp;months following the first occurrence of the good
reason condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &#147;Ownership Change Event&#148; means the occurrence of any of the following with respect to the
Company: (i)&nbsp;the direct or indirect sale or exchange in a single or series of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">related transactions by the stockholders of the Company of more than fifty percent (50%) of the
voting stock of the Company; (ii)&nbsp;a merger or consolidation in which the Company is a party;
or (iii)&nbsp;the sale, exchange, or transfer of all or substantially all of the assets of the Company
(other than a sale, exchange or transfer to one or more subsidiaries of the Company).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;a termination for &#147;Cause&#148; means Executive&#146;s termination based upon (1)&nbsp;Executive&#146;s theft,
dishonesty, misconduct, breach of fiduciary duty, or falsification of any Company documents or
records; (2)&nbsp;Executive&#146;s material failure to abide by the Company&#146;s code of conduct or other
policies (including, without limitation, policies relating to confidentiality and reasonable
workplace conduct); (3)&nbsp;Executive&#146;s unauthorized use, misappropriation, destruction or diversion of
any tangible or intangible asset or corporate opportunity of the Company (including, without
limitation, Executive&#146;s improper use or disclosure of the Company&#146;s confidential or proprietary
information); (4)&nbsp;any intentional act by the Executive that has a material detrimental effect on
the Company&#146;s reputation or business; (5)&nbsp;Executive&#146;s repeated failure or inability to perform any
reasonable assigned duties after written notice from the Company of, and a reasonable opportunity
to cure, such failure or inability; (6)&nbsp;Executive&#146;s conviction (including any plea of guilty or
nolo contendere) for any criminal act that impairs Executive&#146;s ability to perform her duties for
the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) &#147;Separation from Service&#148; shall have the meaning determined by Treasury Regulations issued
pursuant to Section&nbsp;409A.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Termination Without Cause</U>. In the event that the Company or its successor
terminates Executive&#146;s employment without Cause and Executive is not entitled to receive the
severance pay and benefits described in Section&nbsp;3 below, Executive will be entitled to receive the
following payment and benefits, provided that prior to the sixtieth (60th) day following the date
of such termination Executive has signed a general release of known and unknown claims of known and
unknown claims in a form satisfactory to the Company, and the period for revocation has lapsed
without the general release having been revoked:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;payment in a lump sum on the sixtieth (60th) day following Executive&#146;s termination of
employment of an amount equal to six (6)&nbsp;months&#146; base salary at Executive&#146;s final base salary rate,
subject to applicable withholding; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;commencing on the sixtieth (60th) day following Executive&#146;s termination of employment,
payment of the premiums (including reimbursement to Executive of any such premiums paid by
Executive during such sixty (60)&nbsp;day period) necessary to continue Executive&#146;s group health
insurance coverage under COBRA until the earlier of (i)&nbsp;six (6)&nbsp;months following Executive&#146;s
termination date, or (ii)&nbsp;the date on which Executive first becomes eligible to obtain other group
health insurance coverage. Thereafter, Executive may elect to purchase continued group health
insurance coverage at her own expense in accordance with COBRA. Notwithstanding the foregoing,
payment of such premiums shall not commence unless and until Executive has incurred a Separation
from Service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that a Change in Control constituting a change in ownership or effective control
of the Company or a change in the ownership of a substantial portion of the assets of the Company
within the meaning of Section&nbsp;409A (a &#147;Section&nbsp;409A Change in Control Event&#148;)
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">occurs on or before the ninetieth (90th) day following a date on which Executive experiences a
termination of employment in connection with which Executive is entitled to receive the payment
provided by Section&nbsp;2(a), Executive will be entitled to receive the following additional payment
and benefits:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;payment on the sixtieth (60th) day following the Section&nbsp;409A Change in Control Event of
an amount equal to six (6)&nbsp;months&#146; base salary at Executive&#146;s final base salary rate, subject to
applicable withholding; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;commencing with the seventh (7th) month following Executive&#146;s termination of employment,
payment of the premiums necessary to continue Executive&#146;s group health insurance coverage under
COBRA until the earlier of (i)&nbsp;twelve (12)&nbsp;months following Executive&#146;s termination date, or (ii)
the date on which Executive first becomes eligible to obtain other group health insurance coverage.
Thereafter, Executive may elect to purchase continued group health insurance coverage at her own
expense in accordance with COBRA. Notwithstanding the foregoing, payment of such premiums shall
not commence unless and until Executive has incurred a Separation from Service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Termination Without Cause or Resignation for Good Reason Due to a Change in
Control</U>. In the event that, within one (1)&nbsp;year following a Change in Control, the Company or
its successor terminates Executive&#146;s employment without Cause or Executive resigns for Good Reason,
Executive will be entitled to receive the following payment and benefits, provide that prior to the
sixtieth (60th) day following the date of such termination Executive has signed a general release
of known and unknown claims of known and unknown claims in a form satisfactory to the Company, and
the period for revocation has lapsed without the general release having been revoked:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;payment in a lump sum on the sixtieth (60th) day following Executive&#146;s termination of
employment of an amount equal to twelve (12)&nbsp;months&#146; base salary at Executive&#146;s final base salary
rate, subject to applicable withholding; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;commencing on the sixtieth (60th) day following Executive&#146;s termination of employment,
payment of the premiums (including reimbursement to Executive of any such premiums paid by
Executive during such sixty (60)&nbsp;day period) necessary to continue Executive&#146;s group health
insurance coverage under COBRA until the earlier of (i)&nbsp;twelve (12)&nbsp;months following Executive&#146;s
termination date, or (ii)&nbsp;the date on which Executive first becomes eligible to obtain other group
health insurance coverage. Thereafter, Executive may elect to purchase continued group health
insurance coverage at her own expense in accordance with COBRA. Notwithstanding the foregoing,
payment of such premiums shall not commence unless and until Executive has incurred a Separation
from Service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Voluntary Termination</U>. In the event that Executive resigns from her employment
with the Company at any time (other than a resignation for Good Reason during the period covered by
Section&nbsp;3), or in the event that Executive&#146;s employment terminates at any time as a result of her
death or disability (meaning Executive is unable to perform her duties for any consecutive six (6)
month period, with or without reasonable accommodation, as a result of a
physical and/or mental impairment), Executive will be entitled to no compensation or benefits
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">from the Company other than those earned through the date of Executive&#146;s termination. Executive
agrees that if she resigns from her employment with the Company, she will provide the Company with
20 calendar days&#146; written notice of such resignation. The Company may, in its sole discretion,
elect to waive all or any part of such notice period and accept the Executive&#146;s resignation at an
earlier date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Termination for Cause</U>. If Executive&#146;s employment is terminated by the Company at
any time for Cause as defined above in paragraph 1, Executive will be entitled to no compensation
or benefits from the Company other than those earned through the date of her termination for Cause.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Compliance With Section&nbsp;409A.</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Notwithstanding anything set forth herein to the contrary, no amount payable pursuant to
Section&nbsp;2 or Section&nbsp;3 of the Agreement which constitutes a &#147;deferral of compensation&#148; within the
meaning of Treasury Regulations promulgated pursuant to Section&nbsp;409A (the &#147;Section&nbsp;409A
Regulations&#148;) shall be paid unless and until Executive has incurred a Separation from Service.
Furthermore, to the extent that Executive is a &#147;specified employee&#148; of the Company as of the date
of Executive&#146;s separation from service, no amount that constitutes a deferral of compensation which
is payable on account of the Employee&#146;s separation from service shall paid to Executive before the
date (the &#147;Delayed Payment Date&#148;) which is first day of the seventh month after the date of
Executive&#146;s separation from service or, if earlier, the date of Executive&#146;s death following such
separation from service. All such amounts that would, but for this paragraph, become payable prior
to the Delayed Payment Date will be accumulated and paid on the Delayed Payment Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The parties intend that the payments and benefits provided to Executive pursuant to this
Agreement be paid in compliance with Section&nbsp;409A so that no excise tax is incurred under Section
409A. To the extent permitted by Section&nbsp;409A and the Section&nbsp;409A Regulations, the parties agree
to modify this Agreement, the timing (but not the amount(s)) of the payments or benefits provided
herein, or both, to the extent necessary to comply with Section&nbsp;409A.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>At-Will Employment</U>. Notwithstanding anything contained in this Agreement, the
parties acknowledge and agree that Executive&#146;s employment with the Company is and shall continue to
be &#147;at-will.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Dispute Resolution</U>. In the event of any dispute or claim between the parties,
including any claims relating to or arising out of this Agreement or the termination of Executive&#146;s
employment with the Company for any reason, Executive and the Company agree that all such disputes
shall be fully resolved by binding arbitration conducted by the American Arbitration Association
(&#147;AAA&#148;) in Santa Clara County, under the AAA&#146;s National Rules for the Resolution of Employment
Disputes then in effect, which are available online at the AAA&#146;s
website at <U>www.adr.org</U>. Executive
and the Company each acknowledge and agree that they are waiving their respective rights to have
any such disputes or claims tried by a judge or jury.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Notices</U>. Notices and all other communications contemplated by this Agreement shall
be in writing and shall be deemed to have been duly given when personally delivered or when
received if mailed by U.S. registered or certified mail, return receipt requested and postage
prepaid. In the case of the Executive, mailed notices shall be addressed to the Executive at the
home address which the Executive most recently communicated to the Company in writing. In the case
of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices
shall be directed to the attention of its Chief Executive Officer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Successors</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Company&#146;s Successors</U>. Any successor to the Company (whether direct or indirect
and whether by purchase, lease, merger, consolidation, liquidation or purchase of all or
substantially all of the Company&#146;s business and/or assets) shall assume the Company&#146;s obligations
under this Agreement in writing and agree expressly to perform the Company&#146;s obligations under this
Agreement in the same manner and to the same extent that the Company would be required to perform
such obligations in the absence of a succession. For all purposes under this Agreement, the term
&#147;Company&#148; shall include any successor to the Company&#146;s business and/or assets which executes and
delivers the assumption agreement described in this subsection (a)&nbsp;or which becomes bound by the
terms of this Agreement by operation of law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Executive&#146;s Successors</U>. Without the written consent of the Company, the Executive
shall not assign or transfer this Agreement or any right or obligation under this Agreement to any
other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights
of the Executive hereunder shall inure to the benefit of, and be enforceable by, the Executive&#146;s
personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Miscellaneous Provisions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>No Duty to Mitigate</U>. The Executive shall not be required to mitigate the amount
of any payment contemplated by this Agreement, nor shall any such payment be reduced by any
earnings that the Executive may receive from any other source.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Modification/Waiver</U>. No provision of this Agreement may be amended, modified,
waived or discharged unless the amendment, modification, waiver or discharge is agreed to in
writing and signed by the Executive and by an authorized officer of the Company (other than
Executive). No waiver by either party of any breach of, or of compliance with, any condition or
provision of this Agreement by the other party shall be considered a waiver of any other condition
or provision or of the same condition or provision at another time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Integration</U>. This Agreement constitutes the entire agreement and understanding
between the parties regarding Executive&#146;s retention and severance benefits, and it supersedes all
prior or contemporaneous agreements, whether written or oral, regarding that subject matter,
including the Prior Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Choice of Law</U>. The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of California.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Severability</U>. The invalidity or unenforceability of any provision or provisions
of this Agreement shall not affect the validity or enforceability of any other provision hereof,
which shall remain in full force and effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Employment Taxes</U>. All payments made pursuant to this Agreement shall be subject
to withholding of applicable income and employment taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall
be deemed an original, but all of which together will constitute one and the same instrument.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THE PARTIES SIGNING BELOW HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND AND AGREE TO EACH
AND EVERY PROVISION CONTAINED HEREIN.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dated:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;4 December 2008</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;/s/&nbsp;Daniel</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">J. Chavez</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Daniel J. Chavez</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Immersion Corporation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dated:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;4 December 2008</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;/s/ S.M. Ambler</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;CFO/VP Finance</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>f50765exv99w3.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w3</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;99.3</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Investor Contact:<BR>
The Blueshirt Group<BR>
Jennifer Jarman<BR>
&#043;1 415.217.7722<BR>
<u>jennifer@blueshirtgroup.com</u>

</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Daniel Chavez Named Senior Vice President and General<BR>
Manager of Immersion&#146;s Medical Line of Business</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>SAN JOSE, Calif., Dec. 8, 2008 (BUSINESS WIRE) </B>&#151; Immersion Corporation (NASDAQ: IMMR), the leading
developer and licensor of <u>touch feedback technology</u> (<U>http://www.immersion.com/corporate/</U>),
today announced that Daniel Chavez has been named senior vice president and general manager of
Immersion&#146;s Medical line of business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Dan has proven to be a first-class general manager and team leader with a very strong customer
focus,&#148; said Clent Richardson, Immersion president and CEO. &#147;He demonstrates a keen ability to
assess business situations, organize resources, and lead his team to achieve positive results.
Further, he has extensive experience with top-tier medical and healthcare companies as well as a
broad network of relationships. His background, knowledge, and leadership are keys to capturing the
significant global opportunities we have in the medical education and training markets.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dan Chavez has been interim general manager of Immersion&#146;s medical line of business since August.
He has over 25&nbsp;years of general management, sales, and marketing experience in the healthcare
information technology (HIT)&nbsp;industry. Before joining Immersion, he was an HIT industry consultant
focused on business planning, strategic alliance development, product management, and marketing. As
senior vice president of Operations for Availity LLC, he took the company from start up to $35
million in revenue, bringing it recognition as the fastest organically grown eHealth enterprise in
the country. For Science Applications International Corporation (SAIC), he established the
Commercial Health Systems Operation and served as its vice president and general manager. He holds
a Bachelor of Arts degree in Economics from San Jose State University and an MBA from the Stanford
Graduate School of Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Immersion&#146;s solutions are revolutionizing the fields of medical simulation and education,&#148; said
Chavez. &#147;I am intently focused on building and expanding Immersion&#146;s Medical line of business
globally.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About Immersion Medical, Inc. (</B><u><B>www.immersionmedical.com</B></u><B>)</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Immersion Medical, Inc. designs, manufactures, and markets computer-based surgical simulation
training systems (<u>http://www.immersion.com/medical/surgical_sim.php</u>) worldwide. The medical and
surgical simulators integrate proprietary computer software and tactile feedback robotics to create
highly realistic medical simulations that help train
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">clinicians. The company&#146;s key product lines are the Virtual IV system, Endoscopy AccuTouch(R)
simulator, CathLabVR(TM) surgical simulator, and LaparoscopyVR(TM) surgical simulation system.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About Immersion (www.immersion.com)</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Founded in 1993, Immersion Corporation is the recognized leader in developing, licensing, and
marketing digital touch technology and products. Using Immersion&#146;s advanced <u>touch feedback
technology</u> (http://www.immersion.com/corporate/products/), electronic user interfaces are more
compelling, entertaining, and in many applications, safer and more productive. Immersion&#146;s
technology has helped manufacturers develop innovative and creative solutions for products such as
hundreds of video games and leading video console gaming systems, medical training simulators
installed around the world, driver controls for automotive manufacturers, and mobile phones, such
as those from LG and Samsung. Immersion&#146;s patent portfolio includes over 700 issued or pending
patents in the U.S. and other countries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Forward-Looking Statements
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release contains &#147;forward-looking statements&#148; that involve risks and uncertainties as
well as assumptions that, if they never materialize or prove incorrect, could cause the results of
Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed
or implied by such forward-looking statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All statements, other than the statements of historical fact, are statements that may be deemed
forward-looking statements, including any statements of the plans, strategies, and objectives of
management for future operations; any statements concerning consumer or market acceptance of
simulator products for medical education and training; any statements regarding future financial
performance; and statements of belief or assumptions underlying any of the foregoing. Immersion&#146;s
actual results might differ materially from those stated or implied by such forward-looking
statements due to risks and uncertainties associated with Immersion&#146;s business, which include but
are not limited to delay in or failure to achieve commercial demand for Immersion&#146;s expanded
technology offerings; a delay in or failure to achieve the acceptance of force feedback as a
critical user experience in the medical education and training markets; and risks and uncertainties
associated with ongoing and prospective litigation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For a more detailed discussion of these factors and other factors that could cause Immersion&#146;s
actual results to vary materially, interested parties should review the risk factors listed in
Immersion&#146;s most current Form 10-Q, which is on file with the U.S. Securities and Exchange
Commission. The forward-looking statements in this press release reflect Immersion&#146;s beliefs and
predictions as of the date of this release. Immersion disclaims any obligation to update these
forward-looking statements as a result of financial, business, or any other developments occurring
after the date of this release.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Immersion, the Immersion logo, AccuTouch, CathLabVR, and LaparoscopyVR are
trademarks of Immersion Corporation in the United States and other countries. All other trademarks
are the property of their respective owners.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
